Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer

Anxiety & Depression in Thyroid Cancer Patients

NCT06269731 ·Status: NOT_YET_RECRUITING

Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer

NCT01083550 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients

NCT06853925 ·Status: RECRUITING ·Phase: NA

Impact of Conventional Treatments and Clinical Variables on Thyroid Cancer

NCT05752604 ·Status: RECRUITING

Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis)

NCT02156362 ·Status: UNKNOWN ·Phase: NA

Predictive Factors of Clinical, Laboratory and Imaging Findings Routinely Used in Diagnosing Thyroid Cancer

NCT01074684 ·Status: COMPLETED

Evaluating Trends in Anaplastic Thyroid Cancer Patients' Clinical Study Experiences

NCT05819593 ·Status: NOT_YET_RECRUITING

Study of Clinical Outcomes of Thyroid Cancer

NCT04031339 ·Status: UNKNOWN

Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer

NCT06980103 ·Status: RECRUITING ·Phase: NA

Psycho-oncological Intervention Through Counselling in Patients With Differentiated Thyroid Cancer in Treatment With Radioiodine

NCT05054634 ·Status: COMPLETED

Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers

NCT03892993 ·Status: RECRUITING ·Phase: NA

Predicting Prognosis and Recurrence of Thyroid Cancer Via New Biomarkers, Urinary Exosomal Thyroglobulin and Galectin-3

NCT03488134 ·Status: COMPLETED

Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma

NCT06087068 ·Status: RECRUITING ·Phase: PHASE2

Study of the Prevalence of Osteo-metabolic Complications in Patients With Thyroid Cancer

NCT06627998 ·Status: RECRUITING

Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131

NCT00085293 ·Status: COMPLETED ·Phase: PHASE2

Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer

NCT04868045 ·Status: WITHDRAWN ·Phase: PHASE1

Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers

NCT00336102 ·Status: COMPLETED

Leptin Levels in Papillary Thyroid Cancer

NCT01659385 ·Status: COMPLETED

Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW

NCT06095362 ·Status: COMPLETED ·Phase: PHASE1

Studies on Tumors of the Thyroid

NCT00001160 ·Status: RECRUITING

HRQOL in Thyroid Cancer and Thyroid Tumours

NCT03676348 ·Status: RECRUITING

Environmental Factors and Thyroid Cancer

NCT05172921 ·Status: RECRUITING

Outcome of RAI131 Therapy in Patients With Differentiated Thyroid Cancer (Low and Intermediate Risk)

NCT07056218 ·Status: NOT_YET_RECRUITING

Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation

NCT00360074 ·Status: COMPLETED ·Phase: PHASE4

The Usefulness of Staining Lymph Nodes During Operations for Cancer Thyroid in Detecting the Nodes That Have Cancer

NCT00794053 ·Status: COMPLETED ·Phase: PHASE3